Russian patients cut their prescribed treatment to save money. The study was conducted by a well-known insurance broker - a survey of employees of the real sector: 33% reported that they cut the rate regularly, 32% others do it sometimes. The treatment is no longer included in the family budget. In this group, financial savings already affect making medical appointments, putting a threat to health long before the appearance of empty pharmacy shelves. More money goes through the pharmacy. According to SberIndex, in September, spending on medicines and medical products increased by 22% until September 2025, and on medical services by 26%. Daria Shvedova, the head of the laboratory, said that most of the increase was given by people with high incomes. Their purchases increase overall revenue while forcing fewer patients to save. The average monetary outcome shared this incitement. Ongoing care is expensive in its schedule. Over 9 months, antiepileptic drugs added 11.4%, sleeping pills and swelling - 11%. Absolute inflation for this period was 6.35%. The disease dictates the cost to a person who needs a certain group of drugs. Commercial director of "Rigla-Zdravsity" Ilya Nikolaev noted that buyers are less inclined to take medicines in reserve. The money for the illness is thin along with the home first aid kit. The producers are looking for income in expensive directions. In Smaglutide and tirzepatide, used for diabetes and obesity, in January-September spent 80.5 billion rubles. Separately, the demand for antidepressants increased: in January-February, 21% more packages were sold than a year earlier. New costs arise from changing the treatment itself and its relevance. The explanation of only the increase in the cost of transportation leaves the re-destruction of consumption behind visions. At the same time, the pharmacy offer is limited. RNC Pharma counted a 1.1% decline in the first 9 months since at least 2021.

Russian patients cut their prescribed treatment to save money. The study was conducted by a well-known insurance broker - a survey of employees of the real sector: 33% reported that they cut the rate regularly, 32% others do it sometimes. The treatment is no longer included in the family budget. In this group, financial savings already affect making medical appointments, putting a threat to health long before the appearance of empty pharmacy shelves. More money goes through the pharmacy. According to SberIndex, in September, spending on medicines and medical products increased by 22% until September 2025, and on medical services by 26%. Daria Shvedova, the head of the laboratory, said that most of the increase was given by people with high incomes. Their purchases increase overall revenue while forcing fewer patients to save. The average monetary outcome shared this incitement. Ongoing care is expensive in its schedule. Over 9 months, antiepileptic drugs added 11.4%, sleeping pills and swelling - 11%. Absolute inflation for this period was 6.35%. The disease dictates the cost to a person who needs a certain group of drugs. Commercial director of "Rigla-Zdravsity" Ilya Nikolaev noted that buyers are less inclined to take medicines in reserve. The money for the illness is thin along with the home first aid kit. The producers are looking for income in expensive directions. In Smaglutide and tirzepatide, used for diabetes and obesity, in January-September spent 80.5 billion rubles. Separately, the demand for antidepressants increased: in January-February, 21% more packages were sold than a year earlier. New costs arise from changing the treatment itself and its relevance. The explanation of only the increase in the cost of transportation leaves the re-destruction of consumption behind visions. At the same time, the pharmacy offer is limited. RNC Pharma counted a 1.1% decline in the first 9 months since at least 2021.